Mini Review
Published on 13 May 2025
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
- 491 views
145 Publications
Volume 3 - 2024
Volume 4 - 2025
Mini Review
Published on 13 May 2025
Erythroblast island macrophages and their surface markers
Frontiers in Hematology
doi 10.3389/frhem.2025.1580621
- 752 views
Original Research
Published on 06 May 2025
Disease and treatment burden in patients with leukaemia: family members/partner perspective
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
- 802 views
Case Report
Published on 24 Apr 2025
Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
- 1,031 views
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 877 views
Review
Published on 14 Apr 2025
Metabolic reprogramming of fetal hematopoietic stem and progenitor cells by maternal obesity
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
- 817 views
Original Research
Published on 09 Apr 2025
Anemia and its predictors among neonates at Wachemo University teaching hospital, Central Ethiopia: a facility-based cross-sectional study
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
- 884 views
Brief Research Report
Published on 03 Apr 2025
Assessing maternal and perinatal complication incidence in pregnant patients with sickle cell disease: a retrospective analysis of transfusion therapy at a tertiary care hospital
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
- 678 views
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 765 views
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 1,340 views
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 1,641 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 1,016 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 656 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 1,179 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 1,055 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 1,020 views